These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22511874)

  • 21. Stability of BK polyomavirus IgG seroreactivity and its correlation with preceding viremia.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Zaaijer HL; Kroes AC; van Zwet EW; Rotmans JI; Feltkamp MC
    J Clin Virol; 2017 May; 90():46-51. PubMed ID: 28355579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-permissive human conventional CD1c+ dendritic cells enable trans-infection of human primary renal tubular epithelial cells and protect BK polyomavirus from neutralization.
    Sikorski M; Coulon F; Peltier C; Braudeau C; Garcia A; Giraud M; Renaudin K; Kandel-Aznar C; Nedellec S; Hulin P; Branchereau J; Véziers J; Gaboriaud P; Touzé A; Burlaud-Gaillard J; Josien R; McIlroy D; Bressollette-Bodin C; Halary F
    PLoS Pathog; 2021 Feb; 17(2):e1009042. PubMed ID: 33592065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyomavirus BK neutralizing activity in human immunoglobulin preparations.
    Randhawa PS; Schonder K; Shapiro R; Farasati N; Huang Y
    Transplantation; 2010 Jun; 89(12):1462-5. PubMed ID: 20568674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
    Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
    Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation.
    Schachtner T; Stein M; Sefrin A; Babel N; Reinke P
    Transpl Int; 2014 Mar; 27(3):290-301. PubMed ID: 24279642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular immune responses to BK virus.
    Comoli P; Hirsch HH; Ginevri F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):569-74. PubMed ID: 19060544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy.
    Schachtner T; Müller K; Stein M; Diezemann C; Sefrin A; Babel N; Reinke P
    Am J Transplant; 2011 Nov; 11(11):2443-52. PubMed ID: 21831150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients.
    Ginevri F; Azzi A; Hirsch HH; Basso S; Fontana I; Cioni M; Bodaghi S; Salotti V; Rinieri A; Botti G; Perfumo F; Locatelli F; Comoli P
    Am J Transplant; 2007 Dec; 7(12):2727-35. PubMed ID: 17908275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serologic studies of papovavirus infections in pregnant women and renal transplant recipients.
    Andrews CA; Daniel RW; Shah KV
    Prog Clin Biol Res; 1983; 105():133-41. PubMed ID: 6304749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotypic diversity of polyomaviruses circulating among kidney transplant recipients in Kuwait.
    Chehadeh W; Nampoory MR
    J Med Virol; 2013 Sep; 85(9):1624-31. PubMed ID: 23775307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored.
    Leuenberger D; Andresen PA; Gosert R; Binggeli S; Ström EH; Bodaghi S; Rinaldo CH; Hirsch HH
    Clin Vaccine Immunol; 2007 Aug; 14(8):959-68. PubMed ID: 17538118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
    Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C
    Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.
    Alméras C; Vetromile F; Garrigue V; Szwarc I; Foulongne V; Mourad G
    Transpl Infect Dis; 2011 Apr; 13(2):101-8. PubMed ID: 21371220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BK polyomavirus infection and nephropathy: the virus-immune system interplay.
    Babel N; Volk HD; Reinke P
    Nat Rev Nephrol; 2011 May; 7(7):399-406. PubMed ID: 21610680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.
    Chen Y; Trofe J; Gordon J; Autissier P; Woodle ES; Koralnik IJ
    J Clin Virol; 2008 Jun; 42(2):198-202. PubMed ID: 18295538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of BK Virus Genotypes in Recipients of Renal Transplant in Vietnam.
    Toan PQ; Bao Quyen LT; Thu Hang DT; My Anh TT; Cuong LM; Lanh NS; Su HX
    Transplant Proc; 2019 Oct; 51(8):2683-2688. PubMed ID: 31477425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyomavirus BK-specific immunity after kidney transplantation.
    Comoli P; Azzi A; Maccario R; Basso S; Botti G; Basile G; Fontana I; Labirio M; Cometa A; Poli F; Perfumo F; Locatelli F; Ginevri F
    Transplantation; 2004 Oct; 78(8):1229-32. PubMed ID: 15502726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different behaviour of BK-virus infection in liver transplant recipients.
    Umbro I; Tinti F; Muiesan P; Mitterhofer AP
    World J Gastroenterol; 2016 Jan; 22(4):1532-40. PubMed ID: 26819520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
    Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
    J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunoinformatic approach to universal therapeutic vaccine design against BK virus.
    Kesherwani V; Tarang S
    Vaccine; 2019 Jun; 37(26):3457-3463. PubMed ID: 31097352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.